Skip to main content
Top
Published in: International Ophthalmology 2/2017

01-04-2017 | Original Paper

Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy

Authors: Gülizar Demirok, Fatih Kocamaz, Yasemin Topalak, Yeşim Altay, Ahmet Sengun

Published in: International Ophthalmology | Issue 2/2017

Login to get access

Abstract

Central serous chorioretinopathy (CSCR) is characterized by neurosensory retinal detachment. Because the retina pigment epithelium and choroidal pathology is the current mechanism in CSCR, many studies in the literature focused on the outer retinal layers. There is little information about the functional or histological structure of the detached retina. In this study, we assess the ganglion cell complex (GCC) thickness using optical coherence tomography (OCT) in patients with acute and chronic CSCR. The medical records of 16 acute and 19 chronic CSCR patients which have no other disorders that cause a serous macula detachment were analyzed. Chronic cases were also divided into two subgroups: chronic active and chronic nonactive CSCR. The eyes with extramacular involvement or cystoid degeneration and cases which developed choroidal neovascularization were excluded from the study. The mean, minimum, superior-nasal, superior, superior-temporal, inferior-nasal, inferior, and inferior-temporal GCC values obtained using OCT were used for analysis. The duration from the onset was 7.8 ± 4.5 weeks and the mean age was 45.0 ± 10.7 years in acute CSCR, and in chronic cases the values were 36.0 ± 6.2 weeks and 52.9 ± 10.5 years, respectively. There were no significant differences in sex distribution. The chronic cases were statistically significantly older than acute cases (p = 0.02). While there was no difference between the acute and chronic cases, there were statistically significant differences between the chronic CSCR and control group in all values of GCC. Additionally, there were statistically significant differences between the acute CSCR and control group in mean, minimum, and superior-temporal GCC thicknesses. Although choroid and outer retinal layers play an important role in the pathogenesis of CSCR, there is scant information about the functional or histological structure of the detached retina in CSCR. Our results showed that GCC was significantly reduced in both acute and chronic CSCR compared to healthy subjects. Analysis of ganglion cell helps us understand the etiology of the patients which healed anatomically but had limited visual improvement in CSCR.
Literature
1.
go back to reference Velthoven MEJ, Verbraak FD, Garcia PM et al (2005) Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol 89:1483–1488CrossRefPubMedPubMedCentral Velthoven MEJ, Verbraak FD, Garcia PM et al (2005) Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol 89:1483–1488CrossRefPubMedPubMedCentral
3.
go back to reference Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431–448CrossRefPubMed Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431–448CrossRefPubMed
4.
go back to reference Norouzpour A, Abrishami M (2016) Central serous chorioretinopathy: from glucocorticoids to light intensity. Int J Ophthalmol 9:312–314PubMedPubMedCentral Norouzpour A, Abrishami M (2016) Central serous chorioretinopathy: from glucocorticoids to light intensity. Int J Ophthalmol 9:312–314PubMedPubMedCentral
5.
go back to reference Gupta LY, Marmor MF (1996) Electrophysiology of the retinal pigment epithelium in central serous chorioretinopathy. Doc Ophthalmol 91:101–107CrossRef Gupta LY, Marmor MF (1996) Electrophysiology of the retinal pigment epithelium in central serous chorioretinopathy. Doc Ophthalmol 91:101–107CrossRef
6.
go back to reference Hamzah F, Shinojima A, Mori R et al (2014) Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy. BMC Ophthalmol 14:145CrossRefPubMedPubMedCentral Hamzah F, Shinojima A, Mori R et al (2014) Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy. BMC Ophthalmol 14:145CrossRefPubMedPubMedCentral
7.
go back to reference Yun C, Oh J, Han JY et al (2015) Peripapillary choroidal thickness in central serous chorioretinopathy: ıs choroid outside the macula also thick? Retina 35(9):1860–1866CrossRefPubMed Yun C, Oh J, Han JY et al (2015) Peripapillary choroidal thickness in central serous chorioretinopathy: ıs choroid outside the macula also thick? Retina 35(9):1860–1866CrossRefPubMed
8.
go back to reference Goktas A (2014) Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy. Eye (Lond) 28:1431–1436CrossRef Goktas A (2014) Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy. Eye (Lond) 28:1431–1436CrossRef
9.
go back to reference Carrai P, Pichi F, Bonsignore F et al (2015) Wide-field spectral domain-optical coherence tomography in central serous chorioretinopathy. Int Ophthalmol 35:167–171CrossRefPubMed Carrai P, Pichi F, Bonsignore F et al (2015) Wide-field spectral domain-optical coherence tomography in central serous chorioretinopathy. Int Ophthalmol 35:167–171CrossRefPubMed
10.
go back to reference Teke MY, Elgin U, Nalcacioglu-Yuksekkaya P et al (2014) Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy. Int J Ophthalmol 7:350–354PubMedPubMedCentral Teke MY, Elgin U, Nalcacioglu-Yuksekkaya P et al (2014) Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy. Int J Ophthalmol 7:350–354PubMedPubMedCentral
12.
13.
go back to reference Negi A, Marmor MF (1984) Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol 102:445–449CrossRefPubMed Negi A, Marmor MF (1984) Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol 102:445–449CrossRefPubMed
14.
go back to reference Spitznas M, Huke J (1987) Number, shape and topography of leakage points in acute type I central serous retinopathy. Graefes Arch Clin Exp Ophtahlmol. 225:437–440CrossRef Spitznas M, Huke J (1987) Number, shape and topography of leakage points in acute type I central serous retinopathy. Graefes Arch Clin Exp Ophtahlmol. 225:437–440CrossRef
15.
go back to reference Iida T, Spaide RF, Haas A et al (2002) Leopard spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol 120:37–42CrossRefPubMed Iida T, Spaide RF, Haas A et al (2002) Leopard spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol 120:37–42CrossRefPubMed
16.
go back to reference Iijima H, Iida T, Murayama K et al (1999) Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Am J Ophthalmol 127:477–478CrossRefPubMed Iijima H, Iida T, Murayama K et al (1999) Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Am J Ophthalmol 127:477–478CrossRefPubMed
17.
go back to reference Matsuma H, Kishi S, Sato T et al (2011) Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy. Am J Ophthalmol 151:617–623CrossRef Matsuma H, Kishi S, Sato T et al (2011) Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy. Am J Ophthalmol 151:617–623CrossRef
18.
go back to reference Piccolino FC, De La Longrais RR, Ravera G et al (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87–99CrossRefPubMed Piccolino FC, De La Longrais RR, Ravera G et al (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87–99CrossRefPubMed
19.
go back to reference Demirok G, Gul A, Turacli E et al (2015) Choroidal and ganglion cell complex thicknesses in subjects with Type A behavior pattern: an optical coherence tomography study. JCAM. doi:10.4328/JCAM.3253 Demirok G, Gul A, Turacli E et al (2015) Choroidal and ganglion cell complex thicknesses in subjects with Type A behavior pattern: an optical coherence tomography study. JCAM. doi:10.​4328/​JCAM.​3253
20.
21.
go back to reference Tewari HK, Gadia R, Kumar D et al (2006) Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. Invest Ophth Vis Sci 47:3474–3478CrossRef Tewari HK, Gadia R, Kumar D et al (2006) Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. Invest Ophth Vis Sci 47:3474–3478CrossRef
22.
go back to reference Haimovici R, Rumelt S, Melby J (2003) Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 110:698–703CrossRefPubMed Haimovici R, Rumelt S, Melby J (2003) Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 110:698–703CrossRefPubMed
23.
go back to reference Jampol LM, Weinreb R, Yannuzzi L (2002) Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology 109:1765–1766CrossRefPubMed Jampol LM, Weinreb R, Yannuzzi L (2002) Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology 109:1765–1766CrossRefPubMed
24.
go back to reference Gruszka A (2013) Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report. Eur Rev Med Pharmacol Sci 17:1369–1373PubMed Gruszka A (2013) Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report. Eur Rev Med Pharmacol Sci 17:1369–1373PubMed
25.
go back to reference Akyol M, Erol MK, Ozdemir O et al (2015) A novel mutation of sgk-1 gene in central serous chorioretinopathy. Int J Ophthalmol 18:23–28 Akyol M, Erol MK, Ozdemir O et al (2015) A novel mutation of sgk-1 gene in central serous chorioretinopathy. Int J Ophthalmol 18:23–28
26.
go back to reference Ichiseki T, Maatsumoto T, Nishino M et al (2004) Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J Orthop Sci 9:509–515CrossRefPubMed Ichiseki T, Maatsumoto T, Nishino M et al (2004) Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J Orthop Sci 9:509–515CrossRefPubMed
27.
go back to reference Chandra P, Sudhalkar A, Mandal S et al (2015) Retinal circulation and its role in macular disorders in patients without systemic disease. Int J Ophtalmol 8:585–589 Chandra P, Sudhalkar A, Mandal S et al (2015) Retinal circulation and its role in macular disorders in patients without systemic disease. Int J Ophtalmol 8:585–589
Metadata
Title
Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy
Authors
Gülizar Demirok
Fatih Kocamaz
Yasemin Topalak
Yeşim Altay
Ahmet Sengun
Publication date
01-04-2017
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 2/2017
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-016-0278-4

Other articles of this Issue 2/2017

International Ophthalmology 2/2017 Go to the issue